Filing Details

Accession Number:
0000905193-10-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-19 13:00:00
Reporting Period:
2010-05-17
Filing Date:
2010-05-19
Accepted Time:
2010-05-19 18:06:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
275053 Natures Sunshine Products Inc NATR Pharmaceutical Preparations (2834) 870327982
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
905193 K Candace Weir 9 Elk St
Albany NY 12207
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-05-17 2,800 $12.50 1,411,404 No 4 S Indirect By Paradigm Capital Management
Common Stock Disposition 2010-05-18 7,447 $12.51 1,403,957 No 4 S Indirect By Paradigm Capital Management
Common Stock Disposition 2010-05-19 500 $12.50 1,403,457 No 4 S Indirect By Paradigm Capital Management
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Paradigm Capital Management
No 4 S Indirect By Paradigm Capital Management
No 4 S Indirect By Paradigm Capital Management
Footnotes
  1. The shares are beneficially owned by Paradigm Capital Management, Inc. ("Paradigm"), which has sole voting and dispositive power over the shares. As a director and president of Paradigm, Ms. Weir may be deemed to beneficially own, and to have sole voting and dispositive power over, such shares. Ms. Weir disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.58, inclusive. The reporting person undertakes to provide Nature's Sunshine Products, Inc., any security holder of Nature's Sunshine Products, Inc., or the staff of the Securities and Exchange Commision, on request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.